Translational MRI LLC has merged with Hura Imaging INC, please visit www.huraimaging.com
Automated & Multi-Vendor
Post-Processing Solutions
ABOUT US
Translational MRI, LLC (TransMRI) is a high-tech startup company with a focus to develop advanced physiological and functional MRI tools for imaging human brain and body organs.
The goal of TransMRI is to facilitate the translation of these advanced imaging tools for clinical trials and clinical practice.
Particularly, we develop advanced MR pulse sequences and post-processing software based on arterial spin labeling (ASL) techniques for perfusion and angiographic imaging.
We also provide consulting service to pharmaceutical companies on imaging-based clinical trials.
30,000 +
150+
Multi-vendor ASL image datasets processed
Peer-reviewed articles published
510K
FDA clearance 2023
（K211059）
OUR TEAM
Joseph Chow
Founder,General Manager MD, MS
Zhihai Xiang
Partner, BS
Danny Wang
Founder, Scientific Advisor, PhD
Joy Peng
Partner, MS
Jiacheng Li
Programmer, MS
COMPANY NEWS
2017
The company office has been relocated to the TechSpace Incubator which hosts Hi-Tech start-up companies in the beautiful Westwood area on the west side of the LA city.
May
2018
March
A beta version of cloud-based CereFlow (TM) Perfusion has been released and tested at multiple sites globally.
The company team has decided to collaborate with Rook Quality Systems on preparing for FDA 510K submission. RQS is a professional consulting company based in Atlanta, Georgia which is renowned for assisting multiple medical imaging products in their clearance of FDA 510 (k).
June
November
CereFlow (TM) Perfusion V1.0 is officially released. This module provides quantitative and qualitative imaging analysis, generates multi-parametric (CBF, ATT, aCBV) perfusion maps.
2019
January
The trademark of CereFlow (TM) has been registered at USPTO.
CereFlow (TM) MRA Beta version is released for user testing. This module provides 4-D dynamic angiographic imaging post-processing and display, and 3-D time-to-peak (TTP) map.
May
2021
April
The FDA 510 (k) package submission has been completed. A great milestone!
2023
CereFlow (K211059) has been approved by FDA for clinical use
March
TESTIMONY
At our institution, we've been using CereFlow software to provide our neuroradiologists, neurologists, neurosurgery clinicians, and neuroscience researchers with reliable parametric maps of brain perfusion in newborns, neonates, children, and young adults. The cerebral blood flow, arterial transit time, and cerebral blood volume data derived from multi-delay ASL MRI provide clinically important information, and are quite powerful in highlighting focal defects and perfusion asymmetry.
Houchun Harry Hu, PhD
Director of Imaging Research
Department of Radiology
Nationwide Children's Hospital
Columbus, Ohio, USA
TransMRI CereFlow software is highly reliable for all the cases we imaged including children and adults with cerebrovascular disorders, and provides multi-parametric quantitative perfusion information that can aid clinical diagnosis and management of these patients.
Qi Yang, MD
Professor of Radiology,
Beijing Xuanwu Hospital,
Capital Medical University
Beijing, China
CLIENTS
CONTACT
CLIENTS
